Home › NDC Lookup › RxCUI directory › RxCUI 2644526

1.2 ML somatrogon-ghla 50 MG/ML Pen Injector — RxCUI 2644526

RxNorm drug concept · Semantic clinical drug
RxCUI 2644526 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2644526
Official name1.2 ML somatrogon-ghla 50 MG/ML Pen Injector
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assomatrogon-ghla 60 MG per 1.2 ML Pen Injector; somatrogon-ghla 60 MG in 1.2 ML Pen Injector; somatrogon-ghla 50 MG/ML per 1.2 ML Pen Injector
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)2,646 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 1.2 ML somatrogon-ghla 50 MG/ML Pen Injector Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1.2 ML somatrogon-ghla 50 MG/ML Pen Injector RxCUI 2644526

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Somatrogon 2644503
    • Somatrogon-ghla 2644513
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ngenla 2644519
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Somatrogon Pen Injector 2644516
    • Somatrogon-ghla Pen Injector 2645540
    • Somatrogon Injectable Product 2644515
    • Somatrogon-ghla Injectable Product 2662184
    • Somatrogon Pen Injector [Ngenla] 2644522
    • Somatrogon-ghla Pen Injector [Ngenla] 2656910
    • Ngenla Injectable Product 2644521
    • Pen Injector 1649571
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Somatrogon-ghla 50 MG/ML SCDC · 2644525
  • Somatrogon Pen Injector SCDF · 2644516
  • Somatrogon-ghla Pen Injector SCDFP · 2645540
  • Somatrogon Injectable Product SCDG · 2644515
  • Somatrogon-ghla Injectable Product SCDGP · 2662184

Brand-Name Concepts

  • 1.2 ML somatrogon-ghla 50 MG/ML Pen Injector [Ngenla] SBD · 2644529
  • Somatrogon-ghla 50 MG/ML [Ngenla] SBDC · 2644528
  • Somatrogon Pen Injector [Ngenla] SBDF · 2644522
  • Somatrogon-ghla Pen Injector [Ngenla] SBDFP · 2656910
  • Ngenla Injectable Product SBDG · 2644521
  • Ngenla BN · 2644519

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2644526 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00069-0505-02 1 CARTRIDGE in 1 CARTON (0069-0505-02) / 1.2 mL in 1 CARTRI... Ngenla Pfizer Laboratories Div Pfizer Inc 2023-07-31
00069-0520-02 1 CARTRIDGE in 1 CARTON (0069-0520-02) / 1.2 mL in 1 CARTRI... Ngenla Pfizer Laboratories Div Pfizer Inc 2023-07-31
Observed labelers: Pfizer Laboratories Div Pfizer Inc (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.